Novartis (NOVN) vs Johnson & Johnson (JNJ)
Novartis (NOVN) and Johnson & Johnson (JNJ) side by side: both in Healthcare, listed on SIX Swiss Exchange and New York Stock Exchange. Johnson & Johnson is the larger of the two by approximate market capitalization (about 2.2×).
| Field | Novartis | Johnson & Johnson |
|---|---|---|
| Legal name | Novartis AG | Johnson & Johnson |
| Ticker | NOVN | JNJ |
| Exchange | SIX Swiss Exchange XSWX | New York Stock Exchange XNYS |
| Jurisdiction | Switzerland | United States |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharma & MedTech |
| Market cap ≈ | $292.4bn | $645.9bn |
| Founded | 1996 | 1886 |
| Reporting currency | CHF | USD |
| LEI | 5493007HIVTX6SY6XD66 | 549300G0CFPGEF6X2043 |
| ISIN | CH0012005267 | US4781601046 |
| FIGI | BBG001SD31N7 | BBG001S5SHQ9 |
| Index membership | — | S&P 500 |
| Held by (covered funds) | — | — |
Novartis
Basel-based pharmaceutical company created by the 1996 merger of Ciba-Geigy and Sandoz, now a pure-play innovative-medicines business after spinning off Alcon and Sandoz. Key franchises include cardiovascular, oncology and immunology drugs.
Market caps are computed from each issuer's own filed share count times the close on 2026-08-28, not copied from a vendor; LEI from GLEIF (CC0), ISIN read from each issuer's own primary listing document with its ISO 6166 check digit validated, FIGI from OpenFIGI, MIC from the ISO 10383 registry — full provenance on Sources. Not real-time, not investment advice. Both sides as data: /api/v1/companies/novartis · /api/v1/companies/johnson-johnson